Unternehmen XTL Biopharmaceuticals Ltd. TEL AVIV STOCK EXCHANGE
Aktien
XTLB
IL0010854979
XTLB
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Shlomo Shalev
CEO | Chief Executive Officer | 62 | 30.12.14 |
Itay Weinstein
DFI | Director of Finance/CFO | 52 | 01.01.99 |
Doron Turgeman
CHM | Chairman | 56 | 30.12.14 |
Daphna Paran
CTO | Chief Tech/Sci/R&D Officer | - | 04.03.16 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Shlomo Shalev
CEO | Chief Executive Officer | 62 | 30.12.14 |
Director/Board Member | 57 | 29.01.20 | |
Director/Board Member | 53 | 01.04.17 | |
Doron Turgeman
CHM | Chairman | 56 | 30.12.14 |
Director/Board Member | 46 | 08.12.14 | |
Director/Board Member | 57 | 01.03.15 | |
Director/Board Member | 63 | 08.12.14 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 514 205 799 | 479 737 353 ( 93,30 %) | 0 | 93,30 % |
Unternehmenskontakt
XTL Biopharmaceuticals Ltd.
26 Ben-Gurion Street
5112001, Ramat Gan
+972 3 611 6600
http://www.xtlbio.com![Straße XTL Biopharmaceuticals Ltd.(XTLB)](https://cdn.zonebourse.com/static/address/120961698.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+24.74% | 47.96 Mrd. | |
-0.47% | 42.45 Mrd. | |
+43.96% | 41.47 Mrd. | |
+25.40% | 31.6 Mrd. | |
+17.96% | 28.63 Mrd. | |
-4.47% | 28.03 Mrd. | |
+50.73% | 14.56 Mrd. | |
+42.56% | 14.14 Mrd. | |
+1.46% | 12.58 Mrd. |